|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA03060087
|
15-HETE
|
15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060088
|
12-HETE
|
12-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060088
|
12-HETE
|
12-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA08020072
|
N-arachidonoyl dihydroxypropylamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-(1,3-dihydroxy-propyl-2-amine)
|
NA 23:4;O2
|
C23H39NO3
|
377.292994
|
|
LMFA08020072
|
N-arachidonoyl dihydroxypropylamine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-(1,3-dihydroxy-propyl-2-amine)
|
NA 23:4;O2
|
C23H39NO3
|
377.292994
|
|
LMFA03060089
|
9-HETE
|
9-hydroxy-5Z,7E,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060089
|
9-HETE
|
9-hydroxy-5Z,7E,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA04040002
|
15-trans-Neuroprotectin-D1
|
10R,17S-dihydroxy-4Z,7Z,11E,13E,15E,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA04040002
|
15-trans-Neuroprotectin-D1
|
10R,17S-dihydroxy-4Z,7Z,11E,13E,15E,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA01110001
|
Type IV cyanolipid 20:0 ester
|
(1-cyano-2-methylprop-2-en-1-yl) eicosanoate
|
|
C25H45NO2
|
391.345029
|
|
LMFA01110001
|
Type IV cyanolipid 20:0 ester
|
(1-cyano-2-methylprop-2-en-1-yl) eicosanoate
|
|
C25H45NO2
|
391.345029
|
|
LMFA00000001
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
FA 40:7;O3
|
C40H66O5
|
626.491026
|
|
LMFA00000001
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
FA 40:7;O3
|
C40H66O5
|
626.491026
|
|
LMFA00000001
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
2-methoxy-12-methyloctadec-17-en-5-ynoyl anhydride
|
FA 40:7;O3
|
C40H66O5
|
626.491026
|
|
LMFA00000002
|
Serratamic acid
|
N-(3S-hydroxydecanoyl)-L-serine
|
|
C13H25NO5
|
275.173274
|
|
LMFA00000003
|
N-(3-(hexadecanoyloxy)-heptadecanoyl)-L-ornithine
|
N-(3-(hexadecanoyloxy)-heptadecanoyl)-L-ornithine
|
|
C38H74N2O5
|
638.559774
|
|
LMFA00000004
|
N-linolenoyl-glutamine
|
N-(9Z,12Z,15Z-octadecatrienoyl)-glutamine
|
NAGln 18:3
|
C23H38N2O4
|
406.283158
|
|
LMFA00000005
|
N-(3-(15-methyl-hexadecanoyloxy)-13-methyl-tetradecanoyl)-L-serine
|
N-(3-(15-methyl-hexadecanoyloxy)-13-methyl-tetradecanoyl)-L-serine
|
|
C37H71NO6
|
625.528140
|
|
LMFA00000005
|
N-(3-(15-methyl-hexadecanoyloxy)-13-methyl-tetradecanoyl)-L-serine
|
N-(3-(15-methyl-hexadecanoyloxy)-13-methyl-tetradecanoyl)-L-serine
|
|
C37H71NO6
|
625.528140
|
|
LMFA00000006
|
Lysine-containing siolipin
|
2-((2S)-6-amino-2-(3-hydroxy-14-methylpentadecanamido)hexanoyloxy)ethyl 2-hydroxy-13-methyltetradecanoate
|
|
C39H76N2O7
|
684.565254
|
|
LMFA00000006
|
Lysine-containing siolipin
|
2-((2S)-6-amino-2-(3-hydroxy-14-methylpentadecanamido)hexanoyloxy)ethyl 2-hydroxy-13-methyltetradecanoate
|
|
C39H76N2O7
|
684.565254
|
|
LMFA00000006
|
Lysine-containing siolipin
|
2-((2S)-6-amino-2-(3-hydroxy-14-methylpentadecanamido)hexanoyloxy)ethyl 2-hydroxy-13-methyltetradecanoate
|
|
C39H76N2O7
|
684.565254
|
|
LMFA07010004
|
octadecyl 11E-hexadecenoate
|
octadecyl 11E-hexadecenoate
|
WE 34:1
|
C34H66O2
|
506.506281
|
|
LMFA07010005
|
8E-octadecenyl heptadecanoate
|
8E-octadecenyl heptadecanoate
|
WE 36:1
|
C36H70O2
|
534.537581
|
|
LMFA03020031
|
14,15-LTC4
|
15S-hydroxy-14R-(S-glutathionyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C30H47N3O9S
|
625.303303
|
|
LMFA03020031
|
14,15-LTC4
|
15S-hydroxy-14R-(S-glutathionyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C30H47N3O9S
|
625.303303
|
|
LMFA03020031
|
14,15-LTC4
|
15S-hydroxy-14R-(S-glutathionyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C30H47N3O9S
|
625.303303
|
|
LMFA03020032
|
14,15-LTD4
|
15S-hydroxy,14R-(S-cysteinylglycinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C25H40N2O6S
|
496.260709
|
|
LMFA03020032
|
14,15-LTD4
|
15S-hydroxy,14R-(S-cysteinylglycinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C25H40N2O6S
|
496.260709
|
|
LMFA03020032
|
14,15-LTD4
|
15S-hydroxy,14R-(S-cysteinylglycinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C25H40N2O6S
|
496.260709
|
|
LMFA03040003
|
epi-Lipoxin A4
|
5S,6S,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03040003
|
epi-Lipoxin A4
|
5S,6S,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03020033
|
14,15-LTE4
|
15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C23H37NO5S
|
439.239245
|
|
LMFA03020033
|
14,15-LTE4
|
15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C23H37NO5S
|
439.239245
|
|
LMFA03020033
|
14,15-LTE4
|
15S-hydroxy-14R-(S-cysteinyl)-5Z,8Z,10E,12E-eicosatetraenoic acid
|
|
C23H37NO5S
|
439.239245
|
|
LMFA04040003
|
Protectin DX
|
10S,17S-dihydroxy-4Z,7Z,11E,13Z,15E,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA04040003
|
Protectin DX
|
10S,17S-dihydroxy-4Z,7Z,11E,13Z,15E,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA04050001
|
Maresin 1
|
7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA04050001
|
Maresin 1
|
7R,14S-dihydroxy-4Z,8E,10E,12Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O2
|
C22H32O4
|
360.230061
|
|
LMFA08020073
|
N-arachidonoyl L-serine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine
|
NASer 20:4
|
C23H37NO4
|
391.272259
|
|
LMFA08020073
|
N-arachidonoyl L-serine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine
|
NASer 20:4
|
C23H37NO4
|
391.272259
|
|
LMFA08020074
|
N-arachidonoyl GABA
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-gamma-aminobutyric acid
|
NA 24:5;O2
|
C24H39NO3
|
389.292994
|
|
LMFA08020075
|
N-arachidonoyl taurine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine
|
NAT 20:4
|
C22H37NO4S
|
411.244330
|
|
LMFA08020076
|
N-arachidonoyl tyrosine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-tyrosine
|
NATyr 20:4
|
C29H41NO4
|
467.303559
|
|
LMFA08020076
|
N-arachidonoyl tyrosine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-tyrosine
|
NATyr 20:4
|
C29H41NO4
|
467.303559
|
|
LMFA08020076
|
N-arachidonoyl tyrosine
|
N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-tyrosine
|
NATyr 20:4
|
C29H41NO4
|
467.303559
|
|
LMFA08020081
|
N-oleoyl taurine
|
N-(9Z-octadecenoyl)-taurine
|
|
C20H39NO4S
|
389.259980
|
|
LMFA08020082
|
N-oleoyl glycine
|
N-(9Z-octadecenoyl)-glycine
|
NAGly 18:1
|
C20H37NO3
|
339.277344
|
|
LMFA03060091
|
17-HETE
|
17-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|
|
LMFA03060091
|
17-HETE
|
17-hydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
FA 20:4;O
|
C20H32O3
|
320.235146
|